Table 4 |
|||||||
|
Effects of age, sex, surgical status, APACHE II physiological variables, serum albumin and number of organ system failures on ultimate hospital outcome in patients requiring chronic renal dialysis |
|||||||
|
Parameter |
Patients requiring chronic renal dialysis |
Admissions not requiring chronic renal dialysis |
|||||
|
|
|||||||
|
Deaths |
n |
(%) |
Adjusted OR (95% CI) |
P valuee |
Adjusted OR (95% CI) |
P valuef |
|
|
|
|||||||
|
Age (years)* |
1.28 (1.20–1.36) |
< 0.001 |
1.50 (1.49–1.52) |
<0.001 |
|||
|
< 45 |
223 |
681 |
(32.8) |
per 10-year increase |
per 10-year increase |
||
|
45–54 |
234 |
499 |
(46.9) |
||||
|
55–64 |
314 |
711 |
(44.2) |
||||
|
65–74 |
398 |
805 |
(49.4) |
||||
|
75+ |
210 |
351 |
(59.8) |
||||
|
|
|||||||
|
Sex |
0.145 |
0.653 |
|||||
|
Female |
546 |
1,220 |
(44.8) |
Reference |
Reference |
||
|
Male |
833 |
1,827 |
(45.6) |
1.15 (0.95–1.38) |
1.10 (1.07–1.12) |
||
|
|
|||||||
|
Surgical status* |
< 0.001 |
<0.001 |
|||||
|
Elective surgery |
124 |
548 |
(22.6) |
Reference |
Reference |
||
|
Emergency surgery |
194 |
486 |
(39.9) |
1.69 (1.23–2.32) |
2.49 (2.40–2.59) |
||
|
Nonsurgical |
1,061 |
2,012 |
(52.7) |
2.10 (1.59–3.78) |
3.83 (3.69–3.97) |
||
|
|
|||||||
|
Past medical history* |
0.042 |
0.111 |
|||||
|
Absent |
1,121 |
2,563 |
(43.7) |
Reference |
Reference |
||
|
Present |
258 |
484 |
(53.3) |
1.29 (1.01–1.64) |
1.57 (1.52–1.62) |
||
|
|
|||||||
|
CPR before admission* |
< 0.001 |
0.424 |
|||||
|
No |
1,083 |
2,621 |
(41.3) |
Reference |
Reference |
||
|
Yes |
295 |
423 |
(69.7) |
1.90 (1.44–2.52) |
2.14 (2.05–2.22) |
||
|
|
|||||||
|
LOS before admission (days)* |
< 0.001 |
0.053 |
|||||
|
0 |
378 |
863 |
(43.8) |
Reference |
Reference |
||
|
1–2 |
198 |
595 |
(33.3) |
0.76 (0.58–1.00) |
0.99 (0.96–1.02) |
||
|
2–3 |
94 |
240 |
(39.2) |
0.98 (0.69–1.40) |
1.09 (1.04–1.14) |
||
|
3–6 |
197 |
448 |
(44.0) |
0.95 (0.71–1.27) |
1.29 (1.24–1.34) |
||
|
7+ |
511 |
900 |
(56.8) |
1.95 (1.52–2.49) |
1.86 (1.80–1.93) |
||
|
|
|||||||
|
Temperaturea (°C) |
0.783 |
0.078 |
|||||
|
< 34 |
80 |
126 |
(63.5) |
1.24 (0.77–1.99) |
1.96 (1.84–2.08) |
||
|
34–36 |
456 |
946 |
(48.2) |
1.05 (0.85–1.30) |
1.23 (1.19–1.26) |
||
|
36–38.5 |
465 |
1,208 |
(38.5) |
Reference |
Reference |
||
|
38.5–39 |
120 |
274 |
(43.8) |
1.16 (0.85–1.59) |
0.95 (0.91–0.98) |
||
|
≥ 39 |
193 |
382 |
(50.5) |
1.13 (0.84–1.51) |
1.10 (1.06–1.13) |
||
|
|
|||||||
|
Mean arterial pressurea (mmHg)* |
< 0.001 |
<0.001 |
|||||
|
< 50 |
410 |
596 |
(68.8) |
1.96 (1.36–2.83) |
1.96 (1.87–2.04) |
||
|
50–70 |
575 |
1,189 |
(48.4) |
1.29 (0.95–1.75) |
1.21 (1.17–1.25) |
||
|
70–110 |
117 |
351 |
(33.3) |
Reference |
Reference |
||
|
110–130 |
144 |
496 |
(29.0) |
0.74 (0.52–1.05) |
0.96 (0.92–1.00) |
||
|
≥ 130 |
100 |
357 |
(28.0) |
0.62 (0.42–0.92) |
1.26 (1.20–1.32) |
||
|
|
|||||||
|
Heart rateb (beats/min)* |
< 0.001 |
0.638 |
|||||
|
< 50 |
86 |
168 |
(51.2) |
1.34 (0.88–2.06) |
1.15 (1.08–1.22) |
||
|
50–100 |
242 |
780 |
(31.0) |
Reference |
Reference |
||
|
100–110 |
170 |
446 |
(38.1) |
1.23 (0.92–1.64) |
1.11 (1.07–1.16) |
||
|
110–120 |
228 |
486 |
(46.9) |
1.57 (1.18–2.08) |
1.37 (1.32–1.42) |
||
|
120–140 |
373 |
697 |
(53.5) |
1.81 (1.40–2.36) |
1.72 (1.66–1.77) |
||
|
140–155 |
137 |
241 |
(56.9) |
1.86 (1.30–2.66) |
2.15 (2.06–2.24) |
||
|
≥ 155 |
107 |
162 |
(66.0) |
2.09 (1.35–3.23) |
2.52 (2.40–2.64) |
||
|
|
|||||||
|
Respiratory rateb (breaths/min)* |
< 0.001 |
0.082 |
|||||
|
< 6 |
63 |
121 |
(52.1) |
0.99 (0.60–1.64) |
1.22 (1.15–1.30) |
||
|
6–12 |
357 |
881 |
(40.5) |
1.11 (0.84–1.46) |
1.07 (1.04–1.11) |
||
|
12–14 |
230 |
496 |
(46.4) |
1.38 (1.01–1.88) |
1.23 (1.19–1.27) |
||
|
14–25 |
207 |
503 |
(41.2) |
Reference |
Reference |
||
|
25–35 |
269 |
627 |
(42.9) |
1.13 (0.84–1.51) |
0.99 (0.96–1.03) |
||
|
35–40 |
115 |
190 |
(60.5) |
2.11 (1.40–3.18) |
1.25 (1.19–1.32) |
||
|
≥ 40 |
96 |
148 |
(64.9) |
2.32 (1.46–3.68) |
1.49 (1.41–1.56) |
||
|
|
|||||||
|
Oxygenationb (mmHg)* |
0.025 |
0.003 |
|||||
|
A-aDO2 (FiO2 ≥ 0.5) |
|||||||
|
< 250 |
92 |
182 |
(50.6) |
Reference |
Reference |
||
|
250–350 |
187 |
332 |
(56.3) |
1.28 (0.96–1.72) |
1.28 (1.24–1.32) |
||
|
350–500 |
109 |
200 |
(54.5) |
0.73 (0.49–1.07) |
1.56 (1.48–1.63) |
||
|
≥ 500 |
164 |
242 |
(67.8) |
1.26 (0.87–1.84) |
1.70 (1.63–1.77) |
||
|
PaO2 (FiO2 < 0.5) |
|||||||
|
< 50 |
33 |
61 |
(54.1) |
1.53 (0.80–2.93) |
1.06 (0.97–1.16) |
||
|
50–70 |
130 |
295 |
(44.1) |
1.04 (0.77–1.41) |
0.95 (0.92–0.99) |
||
|
70–80 |
128 |
343 |
(37.3) |
0.78 (0.58–1.04) |
0.91 (0.87–0.94) |
||
|
≥ 80 |
352 |
846 |
(41.6) |
Reference |
Reference |
||
|
|
|||||||
|
Arterial pHa* |
< 0.001 |
0.985 |
|||||
|
< 7.15 |
156 |
190 |
(82.1) |
2.65 (1.68–4.18) |
2.95 (2.78–3.13) |
||
|
7.15–7.25 |
157 |
248 |
(63.3) |
1.53 (1.08–2.16) |
1.65 (1.59–1.72) |
||
|
7.25–7.33 |
248 |
544 |
(45.6) |
1.16 (0.92–1.47) |
1.20 (1.16–1.23) |
||
|
7.33–7.5 |
559 |
1,380 |
(40.5) |
Reference |
Reference |
||
|
≥ 7.5 |
79 |
153 |
(51.6) |
1.40 (0.95–2.07) |
1.40 (1.33–1.48) |
||
|
|
|||||||
|
Serum sodiuma (mmol/l)* |
0.035 |
0.079 |
|||||
|
< 130 |
174 |
331 |
(52.6) |
1.44 (1.09–1.90) |
1.43 (1.37–1.48) |
||
|
130–150 |
1,069 |
2,468 |
(43.3) |
Reference |
Reference |
||
|
≥ 150 |
41 |
64 |
(64.1) |
1.12 (0.61–2.07) |
2.26 (2.14–2.39) |
||
|
|
|||||||
|
Serum potassiuma (mmol/l) |
0.180 |
<0.001 |
|||||
|
< 3 |
68 |
125 |
(54.4) |
1.15 (0.74–1.78) |
1.09 (1.04–1.14) |
||
|
3–3.5 |
199 |
379 |
(52.5) |
1.16 (0.89–1.52) |
0.99 (0.96–1.02) |
||
|
3.5–5.5 |
658 |
1,482 |
(44.4) |
Reference |
Reference |
||
|
5.5–6 |
143 |
351 |
(40.7) |
0.91 (0.68–1.21) |
1.26 (1.19–1.32) |
||
|
6–7 |
145 |
370 |
(39.2) |
0.74 (0.55–0.99) |
1.39 (1.31–1.48) |
||
|
≥ 7 |
68 |
153 |
(44.4) |
0.84 (0.55–1.28) |
1.40 (1.25–1.56) |
||
|
|
|||||||
|
Serum creatininea (mg/100 ml) |
0.295 |
0.095 |
|||||
|
< 1.5 |
21 |
73 |
(28.8) |
Reference |
Reference |
||
|
1.5–2 |
28 |
67 |
(41.8) |
0.55 (0.28–1.08) |
1.05 (1.02–1.09) |
||
|
2–3.5 |
152 |
307 |
(49.5) |
0.90 (0.58–1.39) |
1.37 (1.32–1.42) |
||
|
≥ 3.5 |
1,048 |
2,365 |
(44.3) |
0.80 (0.55–1.15) |
1.25 (1.18–1.32) |
||
|
|
|||||||
|
Serum albuminb (g/l)* |
< 0.001 |
0.060 |
|||||
|
< 20 |
453 |
823 |
(55.0) |
1.50 (1.20–1.87) |
1.37 (1.34–1.41) |
||
|
20–25 |
239 |
501 |
(47.7) |
1.35 (1.05–1.72) |
1.00 (0.97–1.03) |
||
|
≥ 25 |
350 |
990 |
(35.4) |
Reference |
Reference |
||
|
|
|||||||
|
Haematocrita (%) |
0.133 |
0.002 |
|||||
|
< 20 |
164 |
324 |
(50.6) |
0.70 (0.49–1.01) |
1.26 (1.18–1.34) |
||
|
20–30 |
790 |
1,769 |
(44.7) |
0.86 (0.70–1.06) |
1.16 (1.14–1.19) |
||
|
≥ 30 |
326 |
751 |
(43.4) |
Reference |
Reference |
||
|
|
|||||||
|
White blood counta (× 1,000/mm3)* |
0.021 |
0.884 |
|||||
|
< 3 |
92 |
129 |
(71.3) |
2.02 (1.26–3.25) |
1.70 (1.60–1.79) |
||
|
3–15 |
586 |
1,577 |
(37.2) |
Reference |
Reference |
||
|
15–20 |
252 |
533 |
(47.3) |
1.05 (0.83–1.33) |
1.13 (1.10–1.17) |
||
|
20–40 |
287 |
508 |
(56.5) |
1.28 (1.00–1.64) |
1.26 (1.22–1.30) |
||
|
≥ 40 |
32 |
48 |
(66.7) |
1.34 (0.67–2.70) |
1.38 (1.25–1.53) |
||
|
|
|||||||
|
Glasgow Coma Scorec* |
1.12 (1.09–1.15) |
< 0.001 |
1.09 (1.09–1.09) |
0.067 |
|||
|
3–6 |
360 |
466 |
(77.3) |
per decrease of 1 |
per decrease of 1 |
||
|
7–9 |
73 |
138 |
(52.9) |
||||
|
10–12 |
77 |
161 |
(47.8) |
||||
|
13–15 |
756 |
2,044 |
(37.0) |
||||
|
|
|||||||
|
Organ system failuresd* |
1.25 (1.07–1.46) |
0.005 |
1.31 (1.28–1.33) |
0.561 |
|||
|
0 |
289 |
1,036 |
(27.9) |
per increase of 1 |
per increase of 1 |
||
|
1 |
469 |
1,077 |
(43.6) |
||||
|
2 |
413 |
662 |
(62.4) |
||||
|
3+ |
208 |
272 |
(76.5) |
||||
|
|
|||||||
|
Sepsis* |
0.022 |
0.060 |
|||||
|
No |
785 |
2,035 |
(38.6) |
Reference |
Reference |
||
|
Yes |
594 |
1,012 |
(58.7) |
1.28 (1.04–1.57) |
1.04 (1.02–1.07) |
||
|
|
|||||||
|
A total of 2,922 patients are included in this analysis. Significant factors (P < 0.05) in the model for admissions of patients requiring chronic renal dialysis are highlighted by asterisks. Exclusions are as follows: readmissions within the same hospital stay; and admissions missing age, sex, surgical status, temperature, mean arterial pressure, heart rate or respiratory rate. Those admissions with missing values for any other physiological variables were assumed to be normal and placed in the reference category. aCategories from Acute Physiology and Chronic Health Evaluation (APACHE) II (reference category equivalent to zero APACHE II points). bCategories from APACHE III (reference category equivalent to zero APACHE III points). cPre-sedation values used for admissions sedated or paralyzed during the first 24 hours in intensive care unit (ICU). dOrgan system failures assessed physiologically, in accordance with the method of Knaus and coworkers [10]. eP value for significance of factor in the end-stage renal failure (ESRF) model. fP value for difference between ESRF and non-ESRF models (test of interaction). A-aDO2, alveolar-arterial oxygen difference; CI, confidence interval; CPR, cardiopulmonary resuscitation; FiO2, fractional inspired oxygen; LOS, length of stay; OR, odds ratio; PaO2, arterial oxygen tension. |
|||||||
|
Hutchison et al. Critical Care 2007 11:R50 doi:10.1186/cc5785 |
|||||||